Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response
- Author
- ESKI, Muhitdin1 ; SAHIN, Ismail1 ; SENGEZER, Mustafa1 ; SERDAR, Muhittin2 ; IFRAN, Ahmet3
[1] Department of Plastic and Reconstructive Surgery and Burn Center, Gulhane Military Medical Academy and Medical School, 06018 Etlik, Ankara, Turkey
[2] Department of Biochemistry, Gulhane Military Medical Academy and Medical School, 06018 Etlik, Ankara, Turkey
[3] Department of Hematology, Gulhane Military Medical Academy and Medical School, 06018 Etlik, Ankara, Turkey - Source
Burns. 2008, Vol 34, Num 1, pp 104-108, 5 p ; ref : 23 ref
- CODEN
- BURND8
- ISSN
- 0305-4179
- Scientific domain
- Anesthesia, intensive care; Dermatology
- Publisher
- Elsevier Science, Oxford
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- Bum injury IL-1 Systemic inflammatory response TNF Thalidomide
- Keyword (fr)
- Antiangiogénique Antibactérien Anticancéreux Antilépreux Brûlure Diminution Facteur nécrose tumorale Hypnotique Inflammation Lésion Médicament Pathologie de la peau Plasma sanguin Psychotrope Systémique Sédatif Thalidomide Anti-TNF-alpha
- Keyword (en)
- Antiangiogenic agent Antibacterial agent Antineoplastic agent Antileprous agent Burn Decrease Tumor necrosis factor Hypnotic Inflammation Lesion Drug Skin disease Blood plasma Psychotropic Systemic Sedative Thalidomide Anti-Tumor Necrosis Factor-alpha
- Keyword (es)
- Antiangiogenico Antibacteriano Anticanceroso Antileproso Quemadura Disminución Factor necrosis tumoral Hipnótico Inflamación Lesión Medicamento Piel patología Plasma sanguíneo Psicotropo Sistémico Sedante Talidomida Anti-TNF alfa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B16 Traumas. Diseases due to physical agents / 002B16J Burns
- Discipline
- Traumas. Diseases caused by physical agents
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 20016238
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.burns.2007.01.007 
https://dx.doi.org/10.1016/j.burns.2007.01.007
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Burns\";s:9:\"\u0000*\u0000stitle\";s:5:\"Burns\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"104\";s:8:\"\u0000*\u0000epage\";s:3:\"108\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0305-4179\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ESKI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Muhitdin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"SAHIN, Ismail\";i:1;s:17:\"SENGEZER, Mustafa\";i:2;s:16:\"SERDAR, Muhittin\";i:3;s:12:\"IFRAN, Ahmet\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BURND8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Burns\";s:9:\"\u0000*\u0000stitle\";s:5:\"Burns\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"104\";s:8:\"\u0000*\u0000epage\";s:3:\"108\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0305-4179\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ESKI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Muhitdin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"SAHIN, Ismail\";i:1;s:17:\"SENGEZER, Mustafa\";i:2;s:16:\"SERDAR, Muhittin\";i:3;s:12:\"IFRAN, Ahmet\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BURND8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Burns\";s:9:\"\u0000*\u0000stitle\";s:5:\"Burns\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"104\";s:8:\"\u0000*\u0000epage\";s:3:\"108\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0305-4179\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ESKI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Muhitdin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"SAHIN, Ismail\";i:1;s:17:\"SENGEZER, Mustafa\";i:2;s:16:\"SERDAR, Muhittin\";i:3;s:12:\"IFRAN, Ahmet\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BURND8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Burns\";s:9:\"\u0000*\u0000stitle\";s:5:\"Burns\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"104\";s:8:\"\u0000*\u0000epage\";s:3:\"108\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0305-4179\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ESKI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Muhitdin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"SAHIN, Ismail\";i:1;s:17:\"SENGEZER, Mustafa\";i:2;s:16:\"SERDAR, Muhittin\";i:3;s:12:\"IFRAN, Ahmet\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BURND8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:27:\"10.1016\/j.burns.2007.01.007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:9:\"\u0000*\u0000jtitle\";s:5:\"Burns\";s:9:\"\u0000*\u0000stitle\";s:5:\"Burns\";s:7:\"\u0000*\u0000date\";s:4:\"2008\";s:9:\"\u0000*\u0000volume\";s:2:\"34\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"104\";s:8:\"\u0000*\u0000epage\";s:3:\"108\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0305-4179\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:4:\"ESKI\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Muhitdin\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:4:{i:0;s:13:\"SAHIN, Ismail\";i:1;s:17:\"SENGEZER, Mustafa\";i:2;s:16:\"SERDAR, Muhittin\";i:3;s:12:\"IFRAN, Ahmet\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BURND8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:145:\"Thalidomide decreases the plasma levels of IL-1 and TNF following burn injury : Is it a new drug for modulation of systemic inflammatory response\";s:8:\"\u0000*\u0000place\";s:6:\"Oxford\";s:6:\"\u0000*\u0000pub\";s:16:\"Elsevier Science\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"5\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
